Creating a World Where Precision Oncology is a Reality for All
Vivek Subbiah, MD, of Sarah Cannon Research Institute, explains what areas need to be addressed to make precision oncology more accessible.
Related Articles
CT‐Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies
Background Older adults with cancer are at an increased risk of treatment related toxicities and early death. Routinely collected clinico-demographic characteristics inadequately explain this increa…
2025 FDA-AACR Workshop: DPD Deficiency and Weighing Potential Harms
AACR is hosting a workshop with the FDA on January 16, 2025, to discuss the considerations for routine testing of DPD deficiency before treatment with…
Ipilimumab plus nivolumab efficacious in patients with dMMR/MSI-H disease
Nature Reviews Clinical Oncology – Ipilimumab plus nivolumab efficacious in patients with dMMR/MSI-H disease
Gritter tracker | Traffic Scotland
Traffic Scotland gives you the real-time information you need about Scotland’s trunk road network
FDA raises recall alert to highest level on Costco eggs over risk of severe illness or death due to salmonella
Regulators warned that eating these eggs could bring “serious adverse health consequences or death.”
Adjuvant Treatment for Endometrial Cancer – Expert Perspectives
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Following surgery for intermediate-…
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review
The diagnosis of myeloid neoplasms with plasmacytoid dendritic cell (pDC) differentiation can be challenging due to immunophenotypic overlap requiring detailed characterization by flow cytometry an…
Careers – KeyCDN
KeyCDN is made up of an international team that has built a high performance content delivery network. Join our team today.
AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
Discover emerging themes and early-stage clinical oncology pipelines at the second AACR Oncology Industry Partnership event.
